Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Is Abbott Laboratories Stock a Buy?
07:30am, Thursday, 17'th Oct 2024
The healthcare stock is lagging the market this year.
Why Abbott Laboratories Stock Was a Winner on Wednesday
06:41pm, Wednesday, 16'th Oct 2024
Investors bumped its shares higher following a decent, if unspectacular, earnings report.
Abbott Stock Gains on Q3 Earnings Beat, Margins Expand
03:00pm, Wednesday, 16'th Oct 2024
ABT delivers a strong underlying base business performance in the third quarter of 2024.
Committee Stocks on the Move: Interactive Brokers, Abbott Labs and Rio Tinto
01:55pm, Wednesday, 16'th Oct 2024
The Investment Committee discuss some of their stocks on the move.
Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript
12:57pm, Wednesday, 16'th Oct 2024
Abbott Laboratories (NYSE:ABT ) Q3 2024 Results Conference Call October 16, 2024 9:00 AM ET Company Participants Mike Comilla - Vice President, Investor Relations Robert Ford - Chairman and Chief Exec
Abbott Laboratories Raises Its Outlook on Strong Medical Device Sales
12:46pm, Wednesday, 16'th Oct 2024
Abbott Laboratories (ABT) shares rose Wednesday, after the drug and healthcare products maker reported better-than-expected quarterly results and raised the midpoint of its profit outlook on strong de
Quarterly Earnings Reports Summary
12:10pm, Wednesday, 16'th Oct 2024
This morning, we see a new print on international trade as well as further articulation on Q3 earnings, particularly in banking/finance and Big Pharma. Pre-market futures are slightly up at this hour:
Imports/Exports Lower; Morgan Stanley, Abbott Beat in Q3
11:35am, Wednesday, 16'th Oct 2024
Both Imports and Exports were deeper into the negative than expected. Meanwhile, MS, ABT and USB all beat of Q3 earnings.
Abbott Q3: Strong Growth In Medical Device And Pharma
11:35am, Wednesday, 16'th Oct 2024
I reiterate a “Strong Buy” rating for Abbott Laboratories with a fair value of $135 per share due to their strong R&D pipeline and robust financial performance. Abbott's recent results show 7.6% o
Here's What Key Metrics Tell Us About Abbott (ABT) Q3 Earnings
10:30am, Wednesday, 16'th Oct 2024
Although the revenue and EPS for Abbott (ABT) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Stree
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
10:03am, Wednesday, 16'th Oct 2024
U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 20 points on Wednesday.
Abbott (ABT) Q3 Earnings and Revenues Surpass Estimates
09:41am, Wednesday, 16'th Oct 2024
Abbott (ABT) came out with quarterly earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.20 per share. This compares to earnings of $1.14 per share a year ago.
Abbott's Growth and Dividends Make It a Smart Portfolio Pick
09:33am, Wednesday, 16'th Oct 2024
There are many reasons to own Abbott Laboratories NYSE: ABT, but they all boil down to one thing: consistent market-beating returns. A study published by Hendrik Bessembinder, a professor of finance a
Abbott Labs beats Q3 sales and earnings expectations, raises full-year outlook
09:16am, Wednesday, 16'th Oct 2024
Abbott Laboratories on Wednesday reported better-than-expected third-quarter earnings and sales, boosted by strength in the company's medical-devices business.
Abbott slightly raises profit forecast on strong medical device sales
07:38am, Wednesday, 16'th Oct 2024
Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for quarterly earnings on strong sales of its medical devices including its glucose-mon
